Statement from FDA Commissioner Scott Gottlieb, M.D., on new actions advancing the agency’s biosimilars policy framework
FDA announces new actions advancing the agency’s biosimilars policy framework
-
Subscribe
Subscribe via the RSS feed
FDA announces new actions advancing the agency’s biosimilars policy framework